Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
Baxter
Mallinckrodt
Colorcon

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Actavis Elizabeth Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and fifteen approved drugs.

There are eight tentative approvals on ACTAVIS ELIZABETH drugs.

Drugs and US Patents for Actavis Elizabeth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth INDAPAMIDE indapamide TABLET;ORAL 074722-002 Jun 17, 1996 AB RX No No   See Pricing   See Pricing
Actavis Elizabeth METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 204161-003 Nov 25, 2016 AB RX No No   See Pricing   See Pricing
Actavis Elizabeth OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040203-001 Mar 15, 1999 DISCN No No   See Pricing   See Pricing
Actavis Elizabeth MORPHINE SULFATE morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 079040-003 Jan 16, 2013 RX No No   See Pricing   See Pricing
Actavis Elizabeth DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 040456-004 May 6, 2003 DISCN No No   See Pricing   See Pricing
Actavis Elizabeth DOXYCYCLINE HYCLATE doxycycline hyclate TABLET, DELAYED RELEASE;ORAL 090134-004 May 22, 2018 AB RX No No   See Pricing   See Pricing
Actavis Elizabeth ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET, EXTENDED RELEASE;ORAL 090869-003 May 17, 2012 AB RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKesson
McKinsey
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.